Tags Posts tagged with "cannabis stocks"

cannabis stocks

0 3774

Canadian licensed medical cannabis producers built off the momentum from Wednesday and benefited from this as it carried into Thursday’s trading session.

These movements are significant because several of these stocks were under pressure on Tuesday and early Wednesday (post-Canopy Growth earnings).

Investors should keep an eye on how this sub-sector continues to trade as we believe it is comprised of some of the highest quality opportunities for investors.

We recapped some of these recent price movements and provided our updated thesis below:

Canopy Growth Corp (WEED.TO: TSX) (TWMJF: OTC) recaptured most of its losses from Tuesday after the shares rallied 3.7% on above-average trading volume. We continue to view Canopy Growth as one of the top long-term cannabis investments due to its leading position in the Canadian medical cannabis market. Canopy Growth recently broke below the $10 level and investor should keep an eye on shares as we continue to see long-term upside to current levels.

OrganiGram Holdings (OGI.V: TSX Venture) (OGRMF: OTC) saw a nice rally yesterday and we will monitor how this continues today. OGI and OGRMF rallied more than 5% and this was a nice change from the recent trend. We will provide updates on any significant price movements today. Stay tuned as we continue to hold cautiously.

Emblem Corp. (EMC.V: TSX Venture) (EMMBF: OTC) continued to rally yesterday and the shares were one of the top performers as they also rallied more than 5%. EMC is trading at $4.17 while EMMBF trades near $3.20. We continue to hold as we are favorable on the long-term outlook. Emblem has a lock up coming up in March and we have started to receive questions about this. Although we expect this to cause a short-term dip, we do not expect it to last long and will keep an eye on any significant price movements leading up to this.

Aurora Cannabis (ACB.V: TSX Venture) (ACBFF: OTC) ended the day up less than 2% and we continue to hold onto the shares. We have contemplated exiting this position and re-entering on weakness, however, we have not decided yet. The reason why we are questioning this holding is due to valuation. When you look at Aurora’s fully-diluted market cap, it is over $1 billion which is significant. We view the risk-reward scenario as balanced here and will keep you updated on how the shares move from here.

Aphria (APH.V: TSX Venture) (APHQF: OTC) edged lower yesterday and this move followed an 18% rally over the last week. APHQF traded as high as $5.15 before ending the day at $4.97 and We continue to see upside to current levels but we may trim the size of our position because of the strength of the recent rally.

CanniMed Therapeutics (CMED.TO: TSX) is trading at $11.95 after the shares edged slightly higher yesterday and we are on the sidelines at current levels. Although we are favorable on the company’s recent execution, the exchange it trades on, and its business model; we are cautious at these levels. We will keep you updated on how the shares trade from here

Cronos Group (MJN.V) recaptured all its losses from Wednesday as the shares rallied approx. 8% yesterday. MJN.V is trading at $2.59 and we are on the sidelines at current levels. We were favorable on MJN after Wednesday’s dip and will monitor how the shares respond today. The company announced a bought deal this week at $2.25 a share and this has caused the shares to trade a little more volatile over the last two trading sessions.

0 1234

MassRoots Provides Business Update and Company Outlook

Recent Company Highlights

  • MassRoots has raised over $2.9 million through warrant exercises so far in 2017, almost entirely from the exercise of the Company’s $0.90 warrants, giving MassRoots its strongest cash position in corporate history.
  • MassRoots anticipates reinstatement in Google Play and the launch of display ads on its Andriod applications by late February 2017, growing the Company’s revenue channels.
  • In late January 2017, MassRoots completed its acquisition of DDDigtal, d.b.a. “Whaxy,” an online order-ahead and menu management platform. Since launching in May 2016, Whaxy’s online ordering platform has processed over $7 million in volume across 60,000 unique transactions.
  • The Company added Mr. Tom Angell as the Company’s Senior Political Correspondent in early February 2017 and has since increased its blog traffic by nearly 18% and received comment from White House Press Secretary Sean Spicer.
  • MassRoots plans to launch its revamped website in early March 2017, in anticipation of its annual web traffic surge ahead of the 4/20 cannabis holiday.

“Our main objective is increasing MassRoots’ market share to 25-35% of cannabis consumers in regulated cannabis markets during 2017,” stated Mr. Isaac Dietrich, CEO of MassRoots Inc.  “By growing the portion of cannabis purchasing decisions being made on the MassRoots platform, we’ll be able to drive more volume and traffic to our preferred dispensary partners. We’ve spent the past year building a strong foundation of strategic partners and loyal users that will allow us to capitalize on the rapidly growing legal cannabis market.  In addition to making significant upgrades to our mobile applications and aligning ourselves with industry leaders, we have also made key hires that will serve vital roles in navigating the rapidly evolving political climate.  We anticipate this framework will result in revenue growth, expansion of our user-base, and increased shareholder value.”

About MassRoots
MassRoots is one of the largest technology platforms for the regulated cannabis industry. The Company’s mobile apps enable consumers to make educated cannabis purchasing decisions through community-drive reviews. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. For more information, please visit MassRoots.com/Investors.

Forward-looking Statements
Certain matters discussed in this announcement contain statements, estimates and projections about the growth of MassRoots’ business, potential partnerships, new features, and related business strategy. Such statements, estimates and projections may constitute forward-looking statements within the meaning of the federal securities laws. Factors or events that could cause our actual results to differ may emerge from time to time. MassRoots undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements.

0 4275

A document that put the DEA under attack for advertising misinformation about cannabis’ health effects has vanished from the agency’s website. An almost 45-page publication on the various consequences of marijuana use, “The Dangers and Consequences of Marijuana Abuse,” no longer was available on the U.S. Drug Enforcement Administration’s website. Last year, the document was at the center of a legal petition by Americans for Safe Access claiming the DEA’s publishing of “scientifically inaccurate information about the health effects of medical cannabis” directly influenced “the action, and inaction, of Congress.”

In December, the medical marijuana advocacy organization alleged that the DEA website’s inclusion of 25 inaccurate statements about cannabis violated the Data Quality Act, also known as the Information Quality Act, which is meant to ensure the quality, objectivity, utility and integrity of data that government agencies provide to the public. Some of those statements, that cannabis plays an important role in psychosis; cannabis smoking causes tumors of the head, neck, and lung; and marijuana is a forerunner to illicit substance use and heroin addiction, have been contradicted by the DEA’s own statements in its August 2016 Denial of Petition to Initiate Proceedings to Reschedule Marijuana, according to ASA.

Agencies have 60 days to respond to requests to correct information, ASA said in its statement. The group recently celebrated the document’s absence as a victory. Steph Sherer, ASA executive director, said in a statement, “The DEA’s removal of these popular myths about cannabis from their website could mean the end of the Washington gridlock. This is a victory for medical cannabis patients across the nation, who rely on cannabis to treat serious illnesses.” In its statement, ASA said “the fight is not over,” claiming that the DEA’s website continues to include misleading or false statements about marijuana.

0 1063

Officials in Denver are working on regulations to open a one-year pilot of bring-your-own weed clubs, while state legislators are expected to consider measures to allow either marijuana “tasting rooms” run by cannabis dispensaries, or smoke-friendly clubs comparable to cigar bars. Colorado representatives from both parties have come around to the idea of Amsterdam-style marijuana clubs for a simple reason: People are tired of seeing weed smokers out in public. State Senator Chris Holbert, a suburban Denver Republican who opposes cannabis legalization stated, “It’s a problem we’ve got to address.” Holbert said he’s even had panhandlers ask him for pot near the state Capitol. Holbert stated, “I mean, look at me. If I’m getting hassled, everyone’s getting hassled.” Democrats here agree that tourists need an out-of-sight place to use marijuana.

State Rep. Dan Pabon, D-Denver stated, “No voter in Colorado voted to allow the use of marijuana on their sidewalk, in their parks, in their public view. But that’s essentially what we’ve done by not allowing private club space for marijuana uses.” So both parties agree that Colorado needs to allow for places that let patrons smoke marijuana. However, that is where agreement breaks down. A Republican-sponsored measure to allow pot clubs to be regulated like cigar bars was put on hold for a revision. That is because sponsors are trying to address issues that marijuana clubs should not allow medical cannabis use, along with other legal wrinkles. Rachel O’Bryan, who opposes marijuana clubs and ran an unsuccessful campaign to defeat a Denver social-use measure last fall stated, “Telling people to socially use their medicine? That’s like we’re legalizing pill parties.” There is also intense conflict over whether establishing marijuana clubs would invite a federal crackdown. Democratic state Representative Jonathan Singer said, “Jeff Sessions is the big question mark right now. I think we need to send a message to him that Colorado’s doing it right.”

Colorado Gov. John Hickenlooper, a Democrat who opposes the legalization of marijuana but is undecided on signing a bill to allow clubs, said he is not sure how the administration would respond to clubs. Hickenlooper stated, “I don’t know whether we’d be inviting federal intervention, but certainly that’s one argument I’ve heard used persuasively.” The governor did indicate he would veto a proposal that allowed indoor smoking, not just smoking on enclosed private patios. The Denver clubs would have to follow clean-air regulations banning burned cannabis inside; the statewide measure would allow indoor smoking with “proper ventilation.” Hickenlooper said, “We spent a long time letting everyone know that smoking is bad for you. Just cause that smoke makes you happy, and dumb, doesn’t mean it’s good for you.”

The cannabis industry seems frustrated by Colorado’s halting attempts to figure out how to allow pot clubs. Because current marijuana law is vague, Colorado currently has a patchwork of underground clubs, many of them raided when they try to pay taxes or file permits. Chris Jetter, a licensed marijuana grower who owned a west Denver pot club that was raided twice, stated, “The situation right now is a disaster.” Jetter said authorities took more than six pounds of cannabis, along with tens of thousands in cash, then charged him with illegally distributing marijuana. Jetter stated, “Two or more people can get together and consume alcohol almost anywhere, and there’s no problem with that. But we’re not treating marijuana like alcohol. What’s going to happen with the feds? If they start kicking in doors, I don’t know, but we need to figure something out.”

0 1130

In Wisconsin, the subject of cannabis for medicinal purposes has been nearly untouched aside from a 2014 proposal that exempted patients with seizure afflictions and a doctor’s recommendation from arrest for possessing or using CBD oil. That proposal didn’t do much to help patients with seizures and nothing to help the many other patients who would benefit from medical cannabis. This year they are making another attempt at passing a CBD proposal that would legalize the use and possession cannabidiol for patients with a doctor’s prescription.

A similar proposal was introduced last year in the Assembly and passed, however, it never made it out of the Senate. This proposal was introduced in the Senate and was approved with a 31-1 vote, with the lone opponent Duey Stroebel, a Republican Senator. While this proposal will open up access to non-psychoactive CBD oil to patients beyond those with seizure disorders, many find that marijuana products with both THC and CBD are more beneficial for most disorders. This means that those this law will help are still greatly limited in comparison to patients in other medical cannabis states.

Sen. Chris Larson, D-Milwaukee, one of the bill’s co-sponsors stated, “If we had done this when the debate first started, it would have cut out four years of suffering for those kids, four years of anguish for those parents.” While it’s likely that this proposal will pass in the Assembly, considering a similar measure made it through last year, there are still too many flaws in the way it’s written. Not only do CBD-only laws limit the number of suffering patients that can legally benefit from medical cannabis, but many don’t create a legal way for patients to access this medicine once a doctor approves it for them in a prescription.

This proposal would not create in-state production or sale of CBD oil, so no matter how patients or caregivers go about it, they are still taking a legal risk just to obtain their medicine. However, while this bill does not go as far as it really needs to, it is at the very least a start. It will give many parents and patients the comfort of knowing at least part of the risk in using their preferred method of treatment has been taken away.

0 1087

The NFL Players’ Association recently reported its intent to urge to the league a “less punitive” approach to dealing with the use of recreational cannabis among players. Union executive director DeMaurice Smith stated, “I do think that issues of addressing it more in a treatment and less punitive measure is appropriate.” Smith did not indicate the changes in the NFLPA’s proposal, which was expected to be presented to the union’s board recently. If passed, it was going to be sent to the league in order to try and collectively negotiate reeform to the drug policy.

NFL commissioner Roger Goodell stated recently, “We certainly haven’t seen it or read it. I’ve spoken to Smith about it. But I think what it’s signaling from our standpoint is that the labor agreement we have has worked incredibly well for the players, for our clubs and for I think the game, in general. It’s encouraged investment. We see the salary cap, which may be projected to increase by $15 million a club. In the last four years alone, the salary cap has jumped almost $1.7 billion including benefits. That’s extraordinary and historically has never come close to being achieved before. So what we have is a labor agreement that’s working well for all parties, but we sent the union last spring a list of issues that we wanted to address as the league and as ownership. I expect, and we put on that list, the drug policy as one of those issues.”

The current collective bargaining agreement runs through 2020, but the league has urged for an extension. Smith said no extension will be agreed upon until changes are made to the current arrangement. Among those changes the NFLPA wants is a new drug policy. Although cannabis is now legal for recreational or medical purposes in more than 24 states, it remains a federally illegal substance. Over the last year, many retired players have urged for the acceptance of hemp and cannabis extracts to treat pain from football-related injuries, and symptoms of brain injuries and concussions.

0 1176

Reliq Health Technologies Signs Agreement with Paz Home Health, TX, USA to Provide Remote Patient Monitoring to More Than 10,000 Home Care Clients

“We are very pleased to be working with Paz Home Health to deliver high quality care to patients in the home,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Reliq’s remote patient monitoring system quickly and easily collects sophisticated health data from patients in their own homes. Our secure, cloud-based care collaboration platform provides the clinical care team, patient and family members with real-time access to patient health information including trends over time. This helps the care team identify patients whose condition is becoming unstable and intervene early, before a serious complication develops. Patients and their loved ones are able to clearly see how compliance with prescribed medication and lifestyle changes affect the patient’s health measures, improving patient engagement and patient- and family-reported satisfaction. Reliq’s virtual care platform was designed to reduce readmissions and improve health outcomes. Our technology allows patients to receive high quality care from the comfort of their own homes, reducing the cost of care delivery and increasing patient and family satisfaction.”

“Our mission at Paz Home Health is to provide peace of mind for patients and their loved ones,” said Dayana Bermea, CEO. “We are excited to be working with Reliq Health to support our care providers in their day-to-day workflow, freeing up more time for patient care. Reliq Health’s cloud-based portal will allow our clients’ family members to access real-time information about their loved one’s health status, care team and home visit schedule. Patients and their families can feel secure knowing that the Reliq Health system will continuously monitor the patient at home and summon emergency services if needed. At Paz Home Health we are always striving to provide our clients with best in class home healthcare.”

Paz Home Health LLC is a home care agency headquartered in Pharr, Texas that provides care to over 10,000 patients across 16 counties in southern Texas. Paz Home Health delivers in-home care from Registered and Licensed Vocational Nurses, Physical and Occupational Therapists, Medical Social Workers and Dieticians. The company also offers telemonitoring services to connect patients with their care team from the comfort of their own homes. Paz Home Health’s caring and qualified healthcare providers are committed to supporting patients and families who are coping with chronic conditions like Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD) and Diabetes, recovering at home from surgery or injuries, and seniors who are aging in place.


Dr. Lisa Crossley, CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

0 1279

VPR Brands, LP is excited to introduce their new RIPPO brand vaporizer

“This is one of the coolest looking items we have ever launched into the market and at $99, it’s going to get everyone’s attention. It looks good plus it feels great in your hand, and once you experience the RIPPO you will understand where the name came from. This is a unit anyone would be proud to carry and pass around when they are out and about with friends or just want to be discrete anywhere at any time. Our Iconic design, new age technology, and quality were brought together by our winning team at VPR Brands which I am proud to be a part of,” says Kevin Frija, VPR Brands CEO. “The RIPPO stands true to its name and then some.”

“We have already pre-sold a large portion of the initial run and plan to build a full line around this concept. I actually took a handmade prototype to MJ Business Conference in Las Vegas and industry professionals offered $200+ for the unit on the spot! From that moment I knew we had to bring this unit to life,” said Dan Hoff, VPR Brands COO. “This piece was designed and built to feel solid in the hands of the beholder, have a feel and function familiar to many while outperforming the competition. This is one of the most powerful compact essential oils vaporizers on the market which provides larger than life hits and extraordinary taste.”

The RIPPO will be available in stores, dispensaries and online www.vapehoneystick.com starting March 1st. The Product will be distributed by Busy Bee distributing and featured product at Canna Daddy’s in Oregon as well as other local distributors and dispensaries in legal states.

Busy Bee Distributing:

We make it easy for retailers to stock their shelves with the products that loyal customers want. The idea is simple, order what your store needs and receive it in one shipment instead of dozens. That’s dozens of intakes you don’t have to process, dozens of vendor payouts you won’t have to manage and dozens of customers that get to work with your most knowledgeable staff members.

We’re really choosy about who we partner with, our thorough application process includes interviews, site visits and product tests in addition to meeting all OHA testing regulations. Why do we bother with all of this? Not only because that’s what will build your business, it’s also because it’s our families and friends who end up using our products. For more information on this company, please visit http://busybeedist.com.

Canna Daddy’s:

We work hand and hand with farmers allowing them to have an opportunity to be promoted and appreciated from our dispensary and from our patients. All of our farms have completed all regulations in testing the medicine that they bring to us to provide to the patient under ORS 333-008-1190. For more information on this company, please visit http://www.canna-daddys.com.

About VPR Brands, LP:

VPR Brands is a technology company, whose assets include issued U.S. and Chinese patents for atomization related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids, vaporizers and electronic cigarettes (also known as e-cigarettes) which are devices which deliver nicotine and or cannabis through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products. For more information about VPR Brands, please visit the company on the web at www.vprbrands.com.

Forward-looking statements:

This news release contains statements that involve expectations, plans or intentions, and other factors discussed from time to time in the company’s Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. The company cautions readers not to place undue reliance on any forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

0 527

NewGen Concepts, Inc., formerly Vapor Group, Inc., VPOR, Launches Demo Video to Promote Easy Grinder™ Worldwide

NewGen Concepts, Inc., formerly Vapor Group, Inc. (OTC Pink: VPOR), (the “Company”), announced that its subsidiary, Total Vapor Inc., launched a new video for Easy Grinder™ which features a live demonstration of it in use. It can be seen at: https://www.youtube.com/watch?v=fveTEGXfG8I and www.easygrinder.com.

The Company’s intent is to have the video go viral in MJ Markets worldwide. In the coming weeks the Company plans to heavily promote this video via social media through online marketing companies, which have an overall reach of over 100 million potential customers.

Retail online pre-orders have been exceedingly strong at $99.00, providing high retail gross margins. As a result, the Company is concentrating on its online retail strategy while it continues to accept significant wholesale pre-orders. Deliveries are planned to begin in March.

For further information or to place wholesale or retail pre-orders, visit us at our website, www.easygrinder.com, or contact sales@easygrinder.com, or call 844-420-EASY (3279).

About NewGen Concepts, Inc.

NewGen Concepts, Inc., www.newgenconcepts.com, acquires and develops commercially viable intellectual property. Formerly named Vapor Group, it previously focused on the manufacture and marketing of high quality vaporizers, e-cigarettes and e-liquids. Through its subsidiary, Smart Wheels, Inc., it also markets “Whizboard” scooters.

Safe Harbor Statement:

This release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words “estimate”, “project”, “intend”, “forecast”, “anticipate”, “plan”, “planning”, “expect”, “believe”, “likely”, “should”, “could”, “would”, “may” or similar words or expressions. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those included within such statements, which involve risks and uncertainties, including those relating to the Company’s ability to grow. Actual results may differ materially from the results predicted and reported results should not be considered an indication of future performance. Potential risks and uncertainties include the Company’s limited operating history and resources, economic conditions, competitive conditions and the conditions of the equity markets.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170216005120/en/

0 970

Vinergy Resources/MJ BioPharma Appoint John Simon to Scientific Advisory Board

John has a Bachelor of Science from the University of Alberta, is a senior member of the American Society for Quality, a Certified Quality Auditor (CQA), a Registered Quality Assurance Professional in Good Laboratory Practice (RQAP-GLP) and maintains Regulatory Affairs Certification (RAC) through the Regulatory Affairs Professional Society.

John has held various management positions in Quality Assurance and Regulatory Affairs and has worked as a consultant supporting clients in the medical device, pharmaceutical, biotechnology and natural health product industries since 2004. He has been directly involved in Federal Drug Administration (FDA) and Health Canada audits of medical device manufacturers, drug manufacturers, testing facilities, and clinical sites. He has experience with submissions to the FDA and Health Canada.

Through John’s consultancy practice he assists companies with both site licenses and product licenses. He has helped companies obtain, renew and maintain in good standing Drug Establishment Licenses (DEL); Medical Device Establishment Licenses (MDEL); Natural and Non-prescription Site Licenses (NNHPD); and Licenses to Cultivate and Distribute under the Marihuana for Medical Purposes Regulations (MMPR) (now under the ACMPR).

John also works in creating quality systems to support ISO certification for various clients (ISO 17025, ISO 13485 and ISO 9001). John consults to groups in the creation of specifications, batch records and procedures to support the design and development of a variety of products including cosmetics, natural health products, medical devices, biologics, pharmaceuticals and controlled substances.

“With John’s substantial background in QA and regulatory affairs specific to drug development and the cannabis industry he will be a key asset in driving our cannabis product and technology initiatives,” said Mr.Kent Deuters, CEO of MJ Biopharma.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

Vinergy Resources Ltd.

Glen Macdonald, Director

Cautionary Statement Regarding “Forward-Looking” Information

The forward-looking information contained in this press release is made as of the date of this press release and, except as required by applicable law, the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking information, whether as a result of new information, future events or otherwise, except as may be required by law. By its very nature, such forward-looking information requires the Company to make assumptions that may not materialize or that may not be accurate. This forward-looking information is subject to known and unknown risks and uncertainties and other factors, which may cause actual results, levels of activity and achievements to differ materially from those expressed or implied by such information. Information pertaining to the Target has been provided by the Target.

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements